Today: 7 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

ONDS Stock Soars on Defense Robotics Deals: What Investors Need to Know on November 25, 2025

ONDS Stock Soars on Defense Robotics Deals: What Investors Need to Know on November 25, 2025

Ondas Holdings Inc. (NASDAQ: ONDS) is back on radar screens this week after a spectacular rally powered by a wave of defense‑focused deals and record quarterly results. The drone and robotics company closed Monday, November 24, 2025, at $8.72 per share, a gain of about 29.5% on the day from a prior close near $6.74, putting the stock near the upper end of its recent trading range.MarketWatch+1 Early data on Tuesday, November 25, 2025, show ONDS changing hands around the same level, with intraday prices so far fluctuating roughly between $6.67 and $8.80 and a 52‑week range of $0.57 to
25 November 2025
··
NVDA Stock Today, November 25, 2025: Nvidia Whipsaws as Meta Eyes Google AI Chips and Wall Street Stays Bullish

NVDA Stock Today, November 25, 2025: Nvidia Whipsaws as Meta Eyes Google AI Chips and Wall Street Stays Bullish

Nvidia stock (NASDAQ: NVDA) is having a volatile session on Tuesday, November 25, 2025, as investors weigh blockbuster AI earnings against fresh competitive worries from Google and Meta. After sliding sharply in premarket trade on reports that Meta Platforms may shift some AI workloads to Google’s custom chips, NVDA has climbed back into positive territory intraday, recently changing hands around $182.55, up roughly 2% on the day based on real-time quotes. Investing.com That bounce comes less than a week after Nvidia reported record quarterly revenue of $57 billion, up 62% year over year, driven largely by its data-center AI business.
25 November 2025
··
Deere & Company (DE) Stock Today: Earnings on Deck as Shares Hover Near $487 – November 25, 2025

Deere & Company (DE) Stock Today: Earnings on Deck as Shares Hover Near $487 – November 25, 2025

Deere & Company (NYSE: DE), the maker of John Deere farm and construction equipment, heads into Tuesday, November 25, 2025 with its stock trading around $487 per share as investors brace for Wednesday’s fiscal Q4 2025 earnings release and guidance for 2026.Fintel The shares sit roughly 10% below their 52‑week high near $534 but remain up mid‑teens percentage year‑to‑date, outpacing many industrial peers despite a weakening agricultural cycle.MarketWatch+2MarketWatch+2 DE stock today: where things stand before earnings On Monday, November 24, Deere closed at $487.23, a gain of about 2.6% on the day as traders continued to position ahead of the
25 November 2025
··
AMPX Stock on November 25, 2025: Amprius Technologies Extends Rebound After Record Q3 Earnings and Korea Battery Alliance

AMPX Stock on November 25, 2025: Amprius Technologies Extends Rebound After Record Q3 Earnings and Korea Battery Alliance

Amprius Technologies (NYSE: AMPX) — the silicon‑anode battery maker behind some of the highest‑energy lithium‑ion cells in the industry — is back on traders’ radar today, November 25, 2025. The stock is riding the afterglow of record third‑quarter results, a new Korea battery alliance, and growing traction in unmanned aerial vehicles (UAVs) and advanced aviation. Below is a data‑driven look at how AMPX stock is trading today, what’s driving sentiment, and the key risks and catalysts investors are watching next. AMPX stock price today (11/25/2025) As of the latest trading data on Tuesday, AMPX is changing hands around $10.80 per
25 November 2025
··
LMT Stock Today (November 25, 2025): Lockheed Martin Slips Again as Record Backlog Meets Market Skepticism

LMT Stock Today (November 25, 2025): Lockheed Martin Slips Again as Record Backlog Meets Market Skepticism

Lockheed Martin (NYSE: LMT) heads into Tuesday’s session under pressure, even as its fundamentals look solid on paper. As of late Monday trading, Lockheed Martin shares were changing hands around $451, down roughly 2.1% from Friday’s close near $460.78, extending a four‑day losing streak. StockInvest Despite that slide, the defense giant just delivered strong third‑quarter 2025 results, raised its full‑year outlook, reported a record $179 billion order backlog, and approved a 5% dividend hike for the fourth quarter. Media – Lockheed Martin+2Reuters+2 Below is a detailed look at where LMT stock stands today, what’s driving sentiment, and what investors will
25 November 2025
·
AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

New York — November 25, 2025 — Axsome Therapeutics (NASDAQ: AXSM) heads into Tuesday’s session trading just below fresh record highs, powered by blockbuster growth from its depression drug Auvelity, the launch of migraine pill Symbravo, and a rapidly expanding neuroscience pipeline. Shares closed on Monday, November 24, at $151.20, up 1.2% on the day and modestly higher in after-hours trading around $152. That puts AXSM near the top of its 52‑week range of $75.56 to $151.39, valuing the CNS-focused biotech at roughly $7.6 billion. StockAnalysis+1 Over the past year, Axsome’s stock has climbed more than 50% (around 54% on
25 November 2025
ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

Key Takeaways ALT stock price today: how Altimmune is trading on November 25, 2025 Altimmune Inc. (NASDAQ: ALT) continues its November rebound. As of early trading on Tuesday, November 25, ALT is changing hands around $5.1 per share, roughly flat to slightly higher versus Monday’s close. Intraday ranges have been tight so far, with trading largely clustered between about $4.8 and $5.2 per share. INDmoney On Monday, November 24, ALT: According to short‑term technical data, ALT has risen in 6 of the last 10 trading days and is up almost 20% over the past two weeks, as traders reposition ahead
25 November 2025
··
Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Frankfurt am Main – 25 November 2025 After one of the sharpest pullbacks in its multi‑year rally, German defence group Rheinmetall AG (Xetra: RHM, ticker: RHM.DE) enters Tuesday’s session under close watch. The stock is trading almost 20% below its early‑November peak, even as the company reports record order books, confirms strong 2025 guidance and lays out an ultra‑ambitious 2030 roadmap. Investing.com+2Yahoo Finance+2 Below is a structured look at where RHM.DE stands today, what’s been driving the latest volatility and the key catalysts investors are likely to focus on over the coming days and months. Rheinmetall share price: a sharp
25 November 2025
··
SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

Shares of Sarepta Therapeutics (NASDAQ: SRPT) head into Tuesday’s session trying to build on a rare rally, as investors digest a positive safety update for its experimental RNA therapy SRP‑1003 and weigh it against fresh FDA warnings and trial setbacks tied to its gene therapy Elevidys. SRPT stock today at a glance As of Monday’s close (November 24, 2025), here’s where SRPT stands: In other words, Monday’s bounce was meaningful, but comes after a brutal collapse from triple‑digit levels earlier in 2025. New SRP‑1003 data: a rare bright spot for SRPT stock On Monday, Sarepta released a progress update for
25 November 2025
··
RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

Rumble Inc. (NASDAQ: RUM) heads into Tuesday’s session on the back of one of its strongest two-day moves of 2025, fueled by fresh commitments from crypto giant Tether and a transformational AI infrastructure deal with Germany’s Northern Data. As of Monday, November 24, RUM closed at $6.51, up about 14.4% on the day, after trading between $5.92 and $6.57 on unusually heavy volume of roughly 7.2 million shares, well above recent averages. FinancialContent That follows a 7% gain on Friday, lifting the stock more than 22% over the last two sessions and putting it back near the upper end of
25 November 2025
···
NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

New Era Energy & Digital, Inc. (NASDAQ: NUAI) heads into Tuesday’s session on the back of a sharp rally and a major expansion update for its flagship Texas AI data center project. As of Monday’s close on November 24, NUAI finished at $4.40, up about 15.8% on the day, with roughly 8.6 million shares traded on the Nasdaq. StockAnalysis The stock remains deeply volatile and, despite the latest bounce, is still down more than 60% over the past 12 months. StockAnalysis This move followed fresh news that the company’s joint venture has locked in more land for its Texas AI
25 November 2025
···
Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s Corporation (NYSE: KSS) heads into a high‑stakes trading day on Tuesday, November 25, 2025, with a fresh CEO, an earnings report due, and the holiday shopping season ramping up—all against a backdrop of heavy short interest and lingering doubts about the department‑store model. As of early Tuesday, KSS is trading around $15.70 per share, giving Kohl’s a market value of roughly $1.8 billion and leaving the stock in the lower half of its 52‑week range of about $6.04 to $21.39. GuruFocus+1 Key Takeaways for KSS Stock on November 25, 2025 KSS Stock Price Today: Volatile but Off the Lows
25 November 2025
·
Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Technologies stock is back under the spotlight today as investors brace for the company’s third‑quarter fiscal 2026 earnings report after the closing bell. Dell shares finished Monday, November 24, at $127.22, up about 3.8% on the day, but still roughly 24% below their early‑November high near $168. StockAnalysis+1 Over the past month, the stock has dropped almost 20%, even after Monday’s rebound, while it remains up around 10% year‑to‑date and down about 12% over the last 12 months. MarketBeat+1 That combination of strong year‑to‑date gains, a sharp recent sell‑off, and a big AI narrative makes Dell one of the
25 November 2025
···
PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

As traders log in on Tuesday, November 25, 2025, Plus Therapeutics (NASDAQ:PSTV) is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and a national coverage agreement with Humana for its CNSide® cancer diagnostic. As of the latest completed trading session on Monday, November 24, PSTV last changed hands at $0.5752, up roughly 8% on the day, after trading between $0.50 and $0.59 on volume of about 8.4 million shares. Even after that bounce, the stock still sits well below its 52‑week high
25 November 2025
·
VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics (NASDAQ: VKTX) heads into the Tuesday, November 25, 2025 session trading in the mid‑$30s, still digesting last week’s major milestone: the company has finished enrolling patients in its pivotal Phase 3 obesity trial VANQUISH‑1 ahead of schedule and above its original target. Viking Therapeutics InvestorRoom As of yesterday’s close (Monday, November 24), VKTX changed hands at $34.65, implying a market capitalization of roughly $3.9 billion. Stock Titan Shares sit well below their 52‑week high of $56.25, but far above the 52‑week low of $18.92, underscoring how volatile the weight‑loss drug trade has become. Investing.com+1 With Phase 3 trials
25 November 2025
··
DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

Diginex Limited (NASDAQ: DGNX) has become one of 2025’s wildest small-cap stories. The ESG and sustainability RegTech firm has seen its DGNX stock rocket more than 1,100% year-to-date, powered by index inclusion, aggressive M&A plans and a wave of interest in compliance-focused AI.Simply Wall St+1 Now, heading into Tuesday, November 25, 2025, DGNX is back in the spotlight after the company signed a non‑binding memorandum of understanding (MOU) to acquire The Remedy Project, a specialist in human-rights risk and worker-centered remediation for global supply chains.ir.diginex.com+2Nasdaq+2 Below is a detailed look at where DGNX stock stands today, what’s driving the latest
25 November 2025
·
Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

As investors head into the Tuesday, November 25 session, Pfizer Inc. (NYSE: PFE) remains one of Wall Street’s most closely watched healthcare names. After a brutal comedown from its pandemic-era highs, the drugmaker is trying to convince the market that a new growth story is taking shape around obesity drugs, oncology and a large – and growing – dividend. As of late Monday trading, Pfizer shares were changing hands around $25 per share, giving the company a market value of roughly $143 billion and placing the stock in the middle of its 52‑week range between $20.92 and $27.69.StockAnalysis+1 At that
25 November 2025
TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had a busy news day on Monday — and the stock still finished sharply lower. Shares of the small-cap biotech closed around $14.29 on November 25, 2025, down roughly 11% on the session, putting the stock well below its recent highs despite a fresh U.S. FDA green light to advance a new depression treatment into Phase 2 trials. TNXP now trades near the lower end of its volatile 52‑week range of $6.76 to $130.00, with a market capitalization of about $168 million. StockAnalysis At the same time, Tonix is transitioning from a pure development-stage
25 November 2025
Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Ticker: BIDU • Exchange: Nasdaq • Date: November 25, 2025 BIDU Stock Jumps as Wall Street Turns More Bullish Baidu’s U.S.-listed shares (NASDAQ: BIDU) rallied sharply on Monday, November 25, 2025, as investors digested fresh analyst upgrades and continued to reposition around the Chinese search and AI giant’s high-spend transformation. By the close, BIDU was trading around $119 per share, up roughly 7.5% on the day from Friday’s $110.95 close. Investing The move added billions of dollars to Baidu’s market value, lifting its market capitalization to around $41 billion. StockAnalysis The rally comes just days after Baidu reported a revenue
25 November 2025
·
Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy Co., Inc. (NYSE: BBY) heads into a critical earnings report tomorrow with its share price under pressure, its dividend yield hovering around 5%, and investors trying to gauge how tariffs and holiday demand will shape the next leg for the stock. On Monday, November 25, 2025, BBY slipped about 1.1% in regular trading to close at $75.62, underperforming a strong broader market rally, before rebounding modestly in after-hours trading to around $76.03.StockAnalysis+1 Below is a look at how BBY traded today, what Wall Street expects from tomorrow’s results, and the key themes that could move the stock through
25 November 2025
1 … 597 598 599 600 601 … 606

Stock Market Today

Exxon Mobil stock price hits a fresh 52-week high near $149 — what could move XOM next week

Exxon Mobil stock price hits a fresh 52-week high near $149 — what could move XOM next week

7 February 2026
NEW YORK, Feb 7, 2026, 10:46 EST — Market closed Exxon Mobil Corp shares closed Friday up 2.03% at $149.05, ending the week at a new high as the energy complex firmed and Wall Street snapped back from a rough stretch. (ExxonMobil) The move matters because Exxon’s stock has been trading like a clean proxy for two things investors are still fighting over: where crude goes next, and how much risk the U.S. market can carry when rates and growth expectations wobble. With U.S. markets shut for the weekend, traders will come into Monday looking first at oil prices and
Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop